Investigating the impact of immune related adverse events, glucocorticoids use and immunotherapy interruption on long-term survival outcomes.

医学 不利影响 不良事件通用术语标准 免疫疗法 内科学 比例危险模型 回顾性队列研究 肿瘤科 队列 癌症 队列研究 生存分析
作者
Charline Lafayolle de la Bruyère,Julien Péron,Pierre Jean Souquet
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:39 (15_suppl): e14551-e14551 被引量:1
标识
DOI:10.1200/jco.2021.39.15_suppl.e14551
摘要

e14551 Background: It remains unclear whether immune related adverse events (irAEs) and glucocorticoids use could impact long term-outcomes in patients treated for solid tumors with immune checkpoint inhibitors (ICI). Methods: All patients treated with a single-agent ICI for any advanced cancer were included in this retrospective multicentric study. Objectives were to assess the impact of grade 3+ irAEs, glucocorticoids use and interruption of immunotherapy on progression free survival (PFS) and overall survival (OS). Data collection was performed retrospectively using a standardized data collection form. Adverse events were categorized as irAEs based on the judgement of the treating physicians, based on the common Terminology Criteria for Adverse Events, version 4.0. Only grade 3 and more irAEs were considered in this study. As irAEs might happen late during the follow-up and progression event or death might happen early, an immortal-time bias might occur as patients responding to ICI will receive the ICI and then be exposed to irAE for a longer period of time. The first occurrence of an irAE was then included in Cox models, as a time-varying covariate. Similar methods were used to evaluate the impact of glucocorticoids introduction or ICI interruption. Results: In this 828 patients’ cohort, 78 patients presented at least one grade 3+ irAE. The first occurrence of grade 3+ irAEs had no significant impact on PFS (HR 0,94; 95%CI 0.7-1.26; p = 0,70) or OS (HR 0.82; 95%CI 0.6-1,12; p = 0,21). 65% of patients with anti CTLA4 and 55% of patients with anti PD(L)1 requested glucocorticoids, which was associated with a significant shorter PFS (adjusted HR 3.0; 95%CI 1.6-5.4; p = 0.00040) and a trend toward shorter OS. Grade 3+ irAEs led to interruption of the ICI in 82 % of patients, which was associated with a significant shorter PFS (adjusted HR 3.5; 95%CI 1.7-6.0; p < 0.00043) and shorter OS (HR 4.5; 95%CI 1.7-12.1; p = 0.0027). The use of glucocorticoids was statistically associated with immunotherapy interruption. Conclusions: In our population of patients treated with single agent ICI, grade 3+ irAEs did not impact long-term outcomes. However, the need for glucocorticoids and the interruption of immunotherapy resulted in poorer long-term outcomes. The impact of grade 3+ irAEs reported in other studies might then be explained by the management of the irAEs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Code_king发布了新的文献求助10
1秒前
雨安完成签到,获得积分10
1秒前
1秒前
喵呜完成签到,获得积分10
1秒前
1秒前
Code_king发布了新的文献求助10
3秒前
Code_king发布了新的文献求助10
3秒前
3秒前
3秒前
Code_king发布了新的文献求助10
4秒前
潇澜发布了新的文献求助10
4秒前
ss发布了新的文献求助10
4秒前
4秒前
4秒前
Code_king发布了新的文献求助10
5秒前
5秒前
6秒前
Code_king发布了新的文献求助10
6秒前
感动书双完成签到,获得积分10
6秒前
6秒前
Code_king发布了新的文献求助10
6秒前
万能图书馆的应助被卡布奇诺采纳,获得10
6秒前
7秒前
7秒前
奥特赛文发布了新的文献求助10
8秒前
9秒前
9秒前
Code_king发布了新的文献求助10
9秒前
Code_king发布了新的文献求助10
10秒前
10秒前
Code_king发布了新的文献求助10
10秒前
10秒前
以钛的应助被重要的溪流采纳,获得10
10秒前
9900发布了新的文献求助10
10秒前
10秒前
10秒前
小郭发布了新的文献求助10
10秒前
Code_king发布了新的文献求助10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177464
求助须知:如何正确求助?哪些是违规求助? 9568344
关于积分的说明 21798806
捐赠科研通 7772101
什么是DOI,文献DOI怎么找? 3432346
关于科研通互助平台的介绍 2556593
邀请新用户注册赠送积分活动 2477882